首页> 外文期刊>The American Journal of Gastroenterology >Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet.
【24h】

Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet.

机译:用无麸质饮食治疗的成人腹腔疾病的粘膜恢复和死亡率。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: Clinical response is typically observed in most adults with celiac disease (CD) after treatment with a gluten-free diet (GFD). The rate of mucosal recovery is less certain. The aims of this study were (1) to estimate the rate of mucosal recovery after GFD in a cohort of adults with CD, and (2) to assess the clinical implications of persistent mucosal damage after GFD. METHODS: The study group included adults with biopsy-proven CD evaluated at the Mayo Clinic who had duodenal biopsies at diagnosis and at least one follow-up intestinal biopsy to assess mucosal recovery after starting a GFD. The primary outcomes of interest were mucosal recovery and all-cause mortality. RESULTS: Of 381 adults with biopsy-proven CD, 241 (73% women) had both a diagnostic and follow-up biopsy available for re-review. Among these 241, the Kaplan-Meier rate of confirmed mucosal recovery at 2 years following diagnosis was 34% (95% confidence interval (CI): 27-40%), and at 5 years was 66% (95% CI: 58-74%). Most patients (82%) had some clinical response to GFD, but it was not a reliable marker of mucosal recovery (P=0.7). Serological response was associated with confirmed mucosal recovery (P=0.01). Poor compliance to GFD (P<0.01), severe CD defined by diarrhea and weight loss (P<0.001), and total villous atrophy at diagnosis (P<0.001) were strongly associated with persistent mucosal damage. There was a trend toward an association between achievement of mucosal recovery and a reduced rate of all-cause mortality (hazard ratio=0.13, 95% CI: 0.02-1.06, P=0.06), adjusted for gender and age. CONCLUSIONS: Mucosal recovery was absent in a substantial portion of adults with CD after treatment with a GFD. There was a borderline significant association between confirmed mucosal recovery (vs. persistent damage) and reduced mortality independent of age and gender. Systematic follow-up with intestinal biopsies may be advisable in patients diagnosed with CD as adults.
机译:目的:通常在使用无麸质饮食(GFD)治疗的大多数患有乳糜泻(CD)的成年人中观察到临床反应。粘膜恢复的速度不确定。这项研究的目的是(1)评估一群CD患者的GFD后GFD后的黏膜恢复率,以及(2)评估GFD后持续黏膜损伤的临床意义。方法:研究组包括在Mayo诊所评估过活检证实CD的成人,他们在诊断时进行了十二指肠活检,并且至少进行了一次肠内活检以评估开始GFD后的粘膜恢复情况。感兴趣的主要结果是粘膜恢复和全因死亡率。结果:在381例经活检证实为CD的成人中,有241例(73%为女性)既有诊断活检又有随访活检可供再次检查。在这241名患者中,诊断后2年确诊粘膜恢复的Kaplan-Meier率为34%(95%置信区间(CI):27-40%),而5年时为66%(95%CI:58- 74%)。大多数患者(82%)对GFD有一定的临床反应,但它不是粘膜恢复的可靠指标(P = 0.7)。血清学反应与确诊的粘膜恢复有关(P = 0.01)。对GFD的依从性差(P <0.01),由腹泻和体重减轻定义的严重CD(P <0.001),诊断时的总绒毛萎缩(P <0.001)与持续的粘膜损害密切相关。根据性别和年龄进行调整后,粘膜恢复的实现与全因死亡率的降低之间存在联系的趋势(危险比= 0.13,95%CI:0.02-1.06,P = 0.06)。结论:在接受GFD治疗后,大部分CD患者没有黏膜恢复。在确认的粘膜恢复(与持续性损害)和降低的死亡率之间存在临界的显着关联,而与年龄和性别无关。对于诊断为CD的成人患者,建议进行肠道活检的系统随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号